MICHELLE REEVES: Open Payments
NPI 1922194018 · SAVANNAH, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$807 in 33 payments from 15 companies in 2025. Trend: 2023 $999 · 2024 $1,070 · 2025 $807
Food & beverage: $735Education: $72
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 9 | $225 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 4 | $70 |
| GENZYME CORPORATION | 2 | $68 |
| Novartis Pharmaceuticals Corporation | 2 | $65 |
| Incyte Corporation | 2 | $54 |
| LEO Pharma Inc. | 2 | $52 |
| Amgen Inc. | 2 | $51 |
| Galderma Laboratories, L.P. | 3 | $50 |
| Organon LLC | 1 | $50 |
| ABBVIE INC. | 1 | $26 |
Products named: TREMFYA, DUPIXENT, COSENTYX, OPZELURA, ANZUPGO, OTEZLA, VTAMA, ILUMYA.
Industry payments across GA — which companies pay providers there.
